MedPath

Outpatient Labor Induction Using Oral Misoprostol in Norway

Not Applicable
Completed
Conditions
Induced; Birth
Labor, Induced
Interventions
Other: Inpatient labor induction
Other: Outpatient labor induction
Registration Number
NCT04746248
Lead Sponsor
Oslo Metropolitan University
Brief Summary

The rate of labor induction has been steadily increasing over the last years, both worldwide and in Norway. Norwegian women are hospitalized when prostaglandins are used to induce labor. In Denmark, a neighboring country to Norway, women have been offered outpatient induction of labor using oral misoprostol for several years.

The overall aim of this study is to investigate if outpatient induction of labor is beneficial in a Norwegian setting. This includes:

1. To investigate the clinical outcomes and feasibility of inducing in an outpatient setting compared to an inpatient setting in Norway

2. To explore low-risk nulliparous women's experiences of labor induction in inpatient and outpatient settings.

This is a non-randomized prospective pilot- and feasibility study, collecting data from electronical records. In addition, the study participants are invited to write a diary during the labor induction process and a questionnaire six weeks postpartum. Eligible patients include low-risk nulliparous women induced with low-dose oral misoprostol.

Detailed Description

The labor induction rate in Norway has increased from 10,5 % in 2000 to 26,1 % in 2019. This represents an important shift in the obstetric care, making labor induction one of the most common obstetrical interventions. The increase alters the population being induced, as it now includes more low-risk births compared to 20 years ago. The low risk labor inductions might not require the same repeated cardiotocography and inpatient care before onset of active labor as complicated pregnancies.

In 2017, a 25 μg misoprostol tablet for oral administration was approved for labor induction in the Nordic countries. Oral administration is user friendly, and low-dose orally administrated misoprostol is considered to have a favorable safety profile compared to many other induction methods, with low risk of hyperstimulation.

Despite the widespread knowledge of the importance of women´s labor experience for her future health, this aspect is rarely thoroughly explored in the vast number of studies on labor induction. For outpatient labor induction to work, it must be an alternative women find beneficial, as well as clinicians and the health care system.

Aim

The overall aim of this study is to investigate if outpatient induction of labor is beneficial in a Norwegian setting. This includes:

Study A. To investigate the clinical outcomes and feasibility of inducing in an outpatient setting compared to an inpatient setting in Norway Study B. To explore low-risk nulliparous women's experiences of labor induction in inpatient and outpatient settings.

Design and methods

Study A is a prospective non-randomized multicenter pilot- and feasibility study. Data are collected from the patient's electronical records. Study B is a mixed methods cross-sectional diary study, collecting data from the participants diaries and questionnaire and their electronical records. Both studies include the same participants.

In both the inpatient and outpatient regime, the women are induced with 25 μg misoprostol tablets administrated orally every two hours. Some of the women will be induced using a balloon catheter before misoprostol. In the inpatient regime, cardiotocography (CTG) will be performed according to standard protocol; every 4-6 hours or on indication. In the outpatient protocol, a CTG will be carried out before and after the administration of the first misoprostol. If the CTG is normal and the woman has no contractions, the woman can go home, provided a normal ultrasound scan from the last three weeks. An appointment will be set up no later than 24 hours later for a new CTG and assessment of the induction process and the health of the woman and fetus. If the woman goes home after this consultation, she will return no later than 24 hours later for inpatient labor induction if the labor does not start.

Women choosing the outpatient protocol will receive oral and written information about what they should be aware of and when to contact the maternity ward. They are welcome to contact the maternity ward at any time to seek advice from a midwife with experience in labor induction.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
200
Inclusion Criteria
  • Healthy nulliparous women
  • A single, healthy fetus in cephalic presentation at gestational age of 37 weeks or more
  • Normal pregnancy
  • The woman can read and communicate in Norwegian
  • No cognitive barriers
  • BMI 15,5-39,9
  • Reside within one hour from the hospital
  • Indication for labor induction is post term pregnancy, uncomplicated pre labor rupture of membranes, maternal wish or other indications determined as low-risk by the attending obstetrician
Exclusion Criteria
  • Known uterine abnormality or previous uterine surgery
  • Major maternal medical illness requiring monitoring of mother or fetus in early labor
  • Maternal infection
  • Pregnancy complications such as preeclampsia, poorly controlled hypertension or medically treated diabetes mellitus
  • Active vaginal bleeding characterized as more than bloody show
  • Smoking
  • Non-reassuring cardiotocography or reduced fetal movement
  • Fetal growth EFW < 10th percentile or >90th percentile
  • Poly- or oligohydramnios
  • Known abnormalities in the placenta or umbilical cord

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Women choosing to stay at the hospitalInpatient labor inductionInclude women who choose to stay at the hospital after implementing an outpatient alternative.
Women choosing to go homeOutpatient labor inductionInclude women who choose the outpatient regime.
Primary Outcome Measures
NameTimeMethod
Deliveries outside the hospitalAt time of delivery

The proportion of deliveries outside the hospital in the outpatient versus inpatient induction group

The proportion of eligible women selecting outpatient labor inductionup to 18 months
Fetal metabolic acidosisFrom delivery and within two hours postpartum

The proportion of fetal metabolic acidosis

Secondary Outcome Measures
NameTimeMethod
Uterine ruptureDuring labor induction or birth
Need for neonatal resuscitation after deliveryWithin two hours after delivery
Delivery modeAt the time of delivery

Mutually exclusive categories, either spontaneous vaginal birth, either instrumental vaginal birth, either operative delivery by cesarean section

Maternal admission to ICU or maternal deathFrom start of induction through discharge, normally within 2-4 days after delivery
Maternal hemorrhage (in ml)During birth and until two hours after delivery
Duration of the stages during induction and birthFrom start of induction until transfer top postpartum ward

Time from start of medication to start of active labor, labor duration, duration of hospital stay

Need for other interventions to induce or augment laborFrom start of induction until start of active labor
ChorioamnionitisDuring birth and until two hours after delivery

Number of participants with clinical chorioamnionitis

Uterine tachysystoleFrom start of induction until delivery
Umbilical cord pH and pCO2Immediately after delivery
Misoprostol administrationFrom start of induction until start of active labor

Total misoprostol dose, delay of medicament administration

Postnatal depression6-8 weeks postpartum

The Edinburgh Postnatal Depression Scale-short version (EPDS-5), Minimum score 0, maximum score 15, cut-off 7 or more The higher the score the more symptoms of depression

Indications for operative deliveryAt the time of delivery

Indications for cesarean delivery or operative vaginal delivery

Perinatal deathFrom start of induction until 1 week after delivery
The experience of labor induction6-8 weeks postpartum

The Experiences of Induction Tool (EXIT), a validated instrument to measure the experiences of labor induction Minimum score per item is 1, maximum is 5, the higher the score the more positive the experience.

The experience of childbirth6-8 weeks postpartum

The Childbirth Experience Questionnaire (CEQ), a validated instrument to measure the experience of childbirth, 4 domains, mean for each domain will be calculated and compared, the higher mean per domain the more positive the birth experience, lowest mean per domain is 1 highest is 4.

Perineal injuryAt the time of delivery

Perineal third or forth degree lacerations and epiosotomy

Presence of meconium in amniotic fluidFrom start of induction until delivery
Admission to NICU due to birth related issuesFrom delivery until discharge, usually 2-4 days after delivery, maximum of 1 week postpartum
Apgar score1, 5 and 10 minutes after delivery

Score 0 to 10 where 10 is highest score indicating most vital neonate

Contact with the hospital during the labor induction processFrom start of induction until hospital admission

Counting number of contacts adding up to a total

The Early Labor ExperienceFrom start of induction until delivery and 6-8 weeks postpartum

Swedish Early Labor Questionnaire for primiparous women (SWE-ELEQ-PP), a validated instrument to measure measure the experience of early labor, 22 items mean score is calculated, higher score is better experience, minimum score per items is 1 maximum is 5

Trial Locations

Locations (2)

Vestre Viken Health Trust, Drammen Hospital

🇳🇴

Drammen, Norway

Oslo University Hospital

🇳🇴

Oslo, Norway

© Copyright 2025. All Rights Reserved by MedPath